Hisakuni Hashimoto - Concepedia

Author

Hisakuni Hashimoto

Also Known As

H Hashimoto, H. HASHIMOTO, H. Hashimoto, HISAKUNI HASHIMOTO, Hashimoto, Hisakuni, Hisakuni HASHIMOTO, Hisakuni Hashimoto

178

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Hamamatsu University School of Medicine University of Shizuoka Hamamatsu University Hamamatsu University Hospital

About

Hisakuni Hashimoto is an author at Hamamatsu University School of Medicine specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	26	747
2	Anesthesia	6	6	151
3	Health Sciences	5	5	128
4	Social Sciences	3	3	136
5	Public Health	2	2	59

Hisakuni Hashimoto

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors Kazufumi Hirano, Ryohei Kimura, Yumi Sugimoto, British Journal of Pharmacology NeurotransmitterPsychopharmacologyLocomotor ActivityPharmacotherapyPlasma Concentration	2005	96
Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide Shinya Fujisawa, Ryuzo Ohno, Kazuyuki Shigeno, Cancer Chemotherapy and Pharmacology Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaPharmacologyHematology	2006	64
Effects of calcium antagonists on the electrical alternans of the ST segment and on associated mechanical alternans during acute coronary occlusion in dogs. Hisakuni Hashimoto, Keiko Suzuki, Seiji Miyake, Circulation Cardiac AnaesthesiaCardiovascular PharmacologyPharmacotherapyTq DepressionSt Segment	1983	62
Effects of Calcineurin Inhibitors on Pharmacokinetics of Mycophenolic Acid and Its Glucuronide Metabolite during the Maintenance Period Following Renal Transplantation Takafumi Naito, Kazuko Shinno, Toshio Maeda, Biological and Pharmaceutical Bulletin Serum CreatinineGlucuronide MetaboliteUrologyMycophenolate MofetilRenal Function	2006	52
Recommended initial loading dose of teicoplanin, established by therapeutic drug monitoring, and outcome in terms of optimal trough level Masaki Sato, Kingo Chida, Takafumi Suda, Journal of Infection and Chemotherapy Therapeutic Drug MonitoringPharmacologyDrug MonitoringPharmacotherapyMedicine	2006	45
Experimental Studies and Clinical Report on the Electrical Alternans of ST Segment during Myocardial Ischemia Mitsuyoshi Nakashima, Hisakuni Hashimoto, Mitsutaka Kanamaru, Japanese Heart Journal	1978	39
Influence of thyroid hormone on the positive inotropic effects mediated by α- and β-adrenoceptors in isolated guinea pig atria and rabbit papillary muscles Hisakuni Hashimoto, Mitsuyoshi Nakashima European Journal of Pharmacology Animal PhysiologyEndocrine MechanismPositive Inotropic EffectsMedicineRabbit Papillary Muscles	1978	39
Changes in Vascular Reactivity in Experimental Diabetic Rats: Comparison with Hypothyroid Rats Yoshiharu Takiguchi, Natsuki Satoh, Hisakuni Hashimoto, Journal of Vascular Research Altered ReactivityMetabolic SyndromeDiabetic NeuropathyNeuroendocrine MechanismHypothalamic Peptide	1988	38
Effects of MS-551, a New Class III Antiarrhythmic Drug, on Programmed Stimulation-Induced Ventricular Arrhythmias, Electrophysiology, and Hemodynamics in a Canine Myocardial Infarction Model Kazunao Kondoh, Hisakuni Hashimoto, Hiroshi Nishiyama, Journal of Cardiovascular Pharmacology Bolus InjectionCardiac MuscleHeart FailureCardiac AnaesthesiaCardiovascular Pharmacology	1994	35
Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development K. Mori, Hisakuni Hashimoto, Hironori Takatsu, Xenobiotica	2009	34

Page 1